An Antigen‐Delivery Protein Nanoparticle Combined with Anti‐PD‐1 Checkpoint Inhibitor Has Curative Efficacy in an Aggressive Melanoma Model is a research paper published in Advanced Therapeutics (2020). On theSindex it has a DataRank of 0. It has been cited 23 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institute of Biomedical Imaging and Bioengineering
Grant: R21EB017995
National Institute of Biomedical Imaging and Bioengineering
Grant: 1R01EB027797‐01
National Institutes of Health
Grant: P30CA062203
NIBIB NIH HHS
Grant: R01 EB027797
National Institutes of Health
Grant: 1R01EB027797-01
Tumor-Associated Antigen Delivery using Protein Nanoparticles for Combined Immunotherapy
National Institutes of Health
Grant: 3P30CA062203-27S1
Clinical Trial Advancement and Development for Sarcomas
National Institutes of Health
Grant: 5R21EB017995-02
Nanoparticle-Modulated Response Against Tumor-Associated Antigens
Fields of Study
Keywords
Sustainable Development Goals